P

Inventor

LICHTLEN PETER

CH10 patents
⚠️ This page may combine multiple inventors who share the name “LICHTLEN PETER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ESBATECH ALCON BIOMED RES UNIT

3 patents
US9683034B2Jun 20, 2017

Stable and soluble antibodies inhibiting TNFα

ESBATECH ALCON BIOMED RES UNIT2 citations72
US8691228B2Apr 8, 2014

Stable and soluble antibodies inhibiting TNFα

ESBATECH ALCON BIOMED RES UNIT0 citations51
US9315572B2Apr 19, 2016

Stable and soluble antibodies inhibiting TNF alpha

ESBATECH ALCON BIOMED RES UNIT0 citations50

EWERT STEFAN

2 patents
US8067547B2Nov 29, 2011

Stable and soluble antibodies inhibiting TNFα

EWERT STEFAN21 citations90
US8389693B2Mar 5, 2013

Stable and soluble antibodies inhibiting TNFα

EWERT STEFAN0 citations49

AUF DER MAUR ADRIAN

2 patents
US8945563B2Feb 3, 2015

Method for treating glioblastoma using antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK

AUF DER MAUR ADRIAN4 citations69
US8936785B2Jan 20, 2015

scFv antibodies which pass epithelial and/or endothelial layers

AUF DER MAUR ADRIAN1 citations47

DELENEX THERAPEUTICS AG

1 patent
US7902340B2Mar 8, 2011

Antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK

DELENEX THERAPEUTICS AG9 citations81

CELL MEDICA SWITZERLAND AG

1 patent
US9512411B2Dec 6, 2016

Nucleic acid encoding antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK

CELL MEDICA SWITZERLAND AG0 citations49

SUCAMPO AG

1 patent
US8835571B2Sep 16, 2014

Fatty acid derivative-polymer conjugate

SUCAMPO AG0 citations41